Loading...
Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy.
Suciu, S Eggermont, A Kirkwood, J Markovic, S Garbe, C Cameron, D Kotapati, S Chen, T Wheatley, K
Suciu, S
Eggermont, A
Kirkwood, J
Markovic, S
Garbe, C
Cameron, D
Kotapati, S
Chen, T
Wheatley, K
Citations
Altmetric:
Abstract
We assessed whether relapse-free survival (RFS; time until recurrence/death) is a valid surrogate for overall survival (OS) among resected stage II-III melanoma patients through a meta-analysis of randomized controlled trials.
Description
Date
2018-01-01
Publisher
Collections
Files
Keywords
Type
Article
Citation
Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy. 2018, 110 (1): J Natl Cancer Inst